MERIDIANDECISION INTELLIGENCEOwner deskOwnerPublic screen
My judgments
MERIDIAN / EXPLORE

From a question,
to the next decision.

View

Skin

YOUR DECISION WORKSPACEOwner onlyStart a new question Open my judgments →Owner operations desk →
Owner sign-in →Signed in as the ownerSign out — see what a visitor sees →End the Cloudflare Access session too →
Reading language
The screen, the questions and the judgments read in English where an English reading has been made. The Korean originals are unchanged, and evidence stays in the language it was written in.

Study · from IATHEON's records

Progress Worth Acting On: Who Decides When a Cancer Result Counts, by When, and What Reopens It

Conquering cancer is a goal; treating a result as progress is a decision someone has to make, again and again. This short study reads ten public texts, from the Cures Act and the Cancer Moonshot to articles on surrogate endpoints, trial success rates and a blood test for many cancers, to ask who decides that a cancer result is worth acting on, by when, and what would make them look again. It finds the deadlines set for programmes rather than results, and the conditions for looking again written down far more often than anyone is bound to act on them.

Source
IATHEON
Cases
0
Length
about 10,000 words
As of
2026-10-07

By RISCON Labs AI from public-domain and openly licensed sources on cancer research and its evaluation · not medical advice · the readings through the works named are this study's interpretation · First edition · October 2026

Start readingThe records at IATHEON
AI-generated editorial illustration: A closed specimen carrier rests between a laboratory and an empty consultation room.

Contents

Before

  1. Abstract1 min
  2. Introduction7 min

Part I · Progress Worth Acting On: Who Decides When a Cancer Result Counts, by When, and What Reopens It

  1. Chapter 1. Who Decides, by When, and What Reopens It19 min
  2. Chapter 2. Appendix: The sources read8 min

After

  1. Conclusion4 min
  2. Sources and bibliography3 min
RISCON Labsrisconlabs.com